- Consumer Products
- Latest 66.44
- Currency US$
- Change 0.74
- Percent Change 1.126 %
- Volume 357,404
- Fri Dec 13, 2013 09:47 AM EST NYSE data delayed 15 minutes.
12 months ended Sep 30, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Nov 8||$0.90||Jan 24||$0.94|
12 months ended Dec 13, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
Covidien PLC, formerly Covidien Ltd, is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. It operates its business through four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. The Medical Devices segment includes the development, manufacture and sale of endomechanical, soft tissue repair, energy, oximetry and monitoring, airway and ventilation, vascular, SharpSafety and clinical care products; Imaging Solutions, which includes the development, manufacture and marketing of radiopharmaceuticals and contrast products; Pharmaceutical Products, which includes the development, manufacture and distribution of dosage pharmaceuticals and active pharmaceutical ingredients, and Medical Supplies, which includes the development, manufacture and sale of nursing care products, medical surgical products and original equipment manufacturer products.